microdose glp 1 pill Microdosing GLP-1: Understanding the Risks Does GLP-1 Microdosing Work For

Cardiovascular outcomes trials have demonstrated reduced rates of major adverse cardiovascular events in high-risk patients treated with liraglutide (LEADER trial) and semaglutide (SUSTAIN-6 trial)

Standard hydration and wellness treatment

With newer GLP-1based therapies now emerging, the field has an opportunity to test whether different drugs in this class have distinct effects on aging biology and to identify which patients may benefit most. Larger clinical trials will be needed to confirm these findings, determine how long the effects persist, and establish optimal dosing strategies and treatment durations for both people with HIV and the broader population

Potential involvement of natural antioxidants in combating reperfusion injury in acute myocardial infarction and ischemic stroke

Fandio J, Vaz AA, Toba L, Roman-Prez M, Gonzlez-Matas L, Mallo F, et al